Ghost Tree Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.47M | Sell |
128,411
-171,589
| -57% | -$8.65M | 1.96% | 19 |
|
|
2024
Q2 | $13.2M | Hold |
300,000
| – | – | 4.13% | 2 |
|
|
2024
Q1 | $15.1M | Buy |
300,000
+220,000
| +275% | +$11.1M | 4.17% | 4 |
|
|
2023
Q4 | $4.83M | Sell |
80,000
-250,000
| -76% | -$15.1M | 1.58% | 13 |
|
|
2023
Q3 | $18.8M | Hold |
330,000
| – | – | 6.19% | 1 |
|
|
2023
Q2 | $16.8M | Buy |
330,000
+135,000
| +69% | +$6.89M | 5.56% | 2 |
|
|
2023
Q1 | $4.17M | Buy |
+195,000
| New | +$4.17M | 1.23% | 28 |
|
|
2022
Q4 | – | Sell |
-300,000
| Closed | -$2.33M | – | 39 |
|
|
2022
Q3 | $2.33M | Hold |
300,000
| – | – | 0.65% | 27 |
|
|
2022
Q2 | $1.58M | Buy |
+300,000
| New | +$1.58M | 0.82% | 25 |
|
|
2021
Q4 | – | Sell |
-500,000
| Closed | -$4.94M | – | 60 |
|
|
2021
Q3 | $4.94M | Hold |
500,000
| – | – | 1.45% | 23 |
|
|
2021
Q2 | $5.18M | Hold |
500,000
| – | – | 1.42% | 25 |
|
|
2021
Q1 | $5.12M | Hold |
500,000
| – | – | 1.2% | 25 |
|
|
2020
Q4 | $5.69M | Buy |
+500,000
| New | +$5.69M | 1.27% | 24 |
|